Cell-mediated immunity is a crucial arm of the immune system that involves the activation and participation of immune cells, particularly T lymphocytes (T cells). This branch of immunity is essential for recognizing and eliminating intracellular pathogens, such as viruses and certain bacteria, as well as abnormal or cancerous cells. Cell-mediated immunity begins with the presentation of antigens by specialized cells, like macrophages and dendritic cells, to T cells. This interaction activates T cells, leading to the differentiation of cytotoxic T cells that directly target and destroy infected or abnormal cells. Helper T cells play a central role in coordinating immune responses by activating other immune cells. Cytokines, signaling molecules released by immune cells, modulate cell-mediated responses and contribute to the regulation of inflammation. The major histocompatibility complex (MHC) plays a key role in presenting antigens to T cells, facilitating the recognition of infected or abnormal cells. Cell-mediated immunity is critical for defense against intracellular pathogens and the surveillance of transformed cells. It also plays a role in autoimmune responses and transplant rejection. Understanding the intricacies of cell-mediated immunity is essential for developing vaccines, immunotherapies, and strategies to manage immune-related disorders.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe